SSA
NVO

Schonfeld Strategic Advisors’s Novo Nordisk NVO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100,500
Closed -$5.11M – 2523
2025
Q4 		$5.11M Hold
100,500
– – 0.02% 533
2025
Q3 		$5.58M Buy
+100,500
New +$5.88M 0.03% 551
2023
Q3 		– Sell
-200,000
Closed -$210K – 2130
2023
Q2 		$210K Hold
200,000
– – ﹤0.01% 1542
2023
Q1 		$320K Buy
+200,000
New +$14.2M ﹤0.01% 1347

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Schonfeld Strategic Advisors's NVO Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in Novo Nordisk (NVO) in Q1 2026: 102,040 shares worth $3.75M. The stake represents 0.03% of the portfolio and ranks #584 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in NVO as recently as Q3 2025.

Schonfeld Strategic Advisors first reported a position in NVO in Q1 2016 and has held it in 21 quarters since. The position peaked at $30.9M in Q3 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Schonfeld Strategic Advisors held 102,040 shares of Novo Nordisk worth $3.75M as of Q1 2026.
  • Novo Nordisk was a new Schonfeld Strategic Advisors position in Q1 2026.
  • Novo Nordisk made up 0.03% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #584 holding.
  • Schonfeld Strategic Advisors first reported a position in Novo Nordisk in Q1 2016 and has held it in 21 quarters since.
  • Schonfeld Strategic Advisors's Novo Nordisk position peaked at $30.9M in Q3 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.